Equifax Inc SEC Filings

Equifax Inc. (EFX) executive reports tax-related share withholding. The company's EVP and Chief HR Officer filed a Form 4 disclosing that on 11/14/2025, 227 shares of Equifax common stock were withheld upon the early vesting of an equal number of restricted stock units to cover taxes associated with the executive becoming retirement eligible. The shares were valued at $204.86 each for this withholding transaction.

After this event, the executive beneficially owned 13,450 shares of Equifax common stock. This total includes accrued dividend equivalent units reinvested in corresponding restricted stock units through the company's last dividend payment date and 270 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan. The transaction reflects routine tax withholding rather than an open-market sale.

Equifax Inc. (EFX) reported an insider transaction by its EVP, CFO & COO on a Form 4. On 11/14/2025, 202 shares of common stock were withheld at a price of $204.86 per share to cover taxes due on the early vesting of an equal number of restricted stock units after the executive became retirement eligible. Following this tax withholding, the reporting person directly beneficially owns 62,027 shares, which include accrued dividend equivalent units from reinvested dividends.

Equifax Inc. executive files Form 4 reporting tax withholding on vested stock units. The company's EVP and Chief Legal Officer reported that on 11/14/2025, 260 shares of Equifax common stock were withheld at a price of $204.86 per share to cover taxes due when an equal number of restricted stock units vested early as the executive became retirement eligible. After this withholding transaction, the reporting person beneficially owned 15,927 shares of Equifax common stock, which include dividend equivalent units that were reinvested in corresponding restricted stock units through the company's most recent dividend payment date.

The Vanguard Group filed Amendment No. 14 to Schedule 13G reporting a passive beneficial ownership stake in Equifax Inc. (EFX). Vanguard reported 15,282,951 shares beneficially owned, representing 12.34% of the class as of 09/30/2025.

Vanguard reported 0 shares with sole voting power and 731,561 shares with shared voting power. It disclosed 14,103,287 shares with sole dispositive power and 1,179,664 shares with shared dispositive power. Vanguard certified the securities were acquired and held in the ordinary course and not for the purpose of changing or influencing control. Vanguard noted its clients have the right to receive dividends or proceeds, and no one other person's interest exceeds 5%.

Equifax (EFX) CEO and director reported insider transactions on 10/27/2025. The reporting person exercised 27,959 stock options at $191.44 and executed multiple open‑market sales under a Rule 10b5‑1 trading plan adopted on 11/14/2024, plus a G code gift of 47 shares.

Sales included 6,943 shares at a weighted average price of $232.1887 and 6,639 shares at $230.184, among other tranches disclosed. Following the reported transactions, direct beneficial ownership was 142,934 shares. Indirect holdings in grantor retained annuity trusts (GRATs) remained, including 22,045 shares in the “2‑yr Jun 2025 GRAT” and 16,287 shares in the “3‑yr Jul 2024 GRAT.”

Equifax (EFX) reported an insider transaction by its EVP, Chief Technology Officer. On 10/27/2025, the officer exercised options for 4,925 shares of common stock at $175.48 per share (code M) and sold 4,925 shares at $238.94 (code S) pursuant to a Rule 10b5-1 trading plan adopted on 4/25/2025.

Following these transactions, the officer directly beneficially owned 39,364 shares. The option related to 4,925 underlying shares had an exercise price of $175.48 and an expiration of 02/21/2026, and vested in three equal annual increments beginning 2/21/2021. Holdings include accrued dividend equivalent units and shares acquired via the company’s 2020 Employee Stock Purchase Plan.

Equifax Inc. filed a Form 144 notice for a proposed sale of 49,345 common shares. The filing lists Fidelity Brokerage Services as broker and an aggregate market value of $11,404,110.96, with an approximate sale date of 10/27/2025 on the NYSE.

The shares to be sold reflect prior acquisitions: 21,386 shares from restricted stock vesting on 05/04/2021 (compensation) and 27,959 shares tied to an option granted on 02/21/2020, with cash payment dated 10/27/2025. Shares outstanding were 122,394,037; this is a baseline figure, not the amount being sold.

The filing also notes a sale during the prior three months: Mark W. Begor sold 48,264 common shares on 07/28/2025 for gross proceeds of $11,666,012.59.

Form 144 notice filed for a proposed sale of 4,925 common shares. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 10/27/2025. The filing lists an aggregate market value of $1,176,779.50 for the proposed sale.

The seller acquired 4,925 shares on 10/27/2025 via an option originally granted on 02/21/2020, with payment noted as cash. The filing also cites 122,394,037 shares outstanding; this is a baseline figure, not the amount being offered.

Equifax Inc. reported Q3 2025 results with operating revenue of $1,544.9 million, up 7% year over year, and operating income of $264.3 million. Diluted EPS was $1.29 versus $1.13 a year ago as segment growth offset higher SG&A and depreciation. Interest expense declined to $52.2 million.

Growth was broad-based: Workforce Solutions revenue rose to $649.4 million (+5%), U.S. Information Solutions to $530.2 million (+11%), and International to $365.3 million (+6%). Year to date, cash provided by operating activities was $1,144.9 million with capital expenditures of $349.1 million. The company repurchased $300.0 million of shares in Q3 (1.24 million shares) and paid a quarterly dividend of $0.50 per share. Total debt was $4,835.6 million with $1.4 billion available under the Revolver at September 30, 2025.